GlassScriptPhysician profile
Kevin Lollar
NPI 1174627350
$3,085.63
in general payments reported to CMS, 2019-2025
19 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $187 · 2021: $540 · 2022: $662 · 2023: $203 · 2024: $322 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.34 |
| Education | $173.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $915.04 | 2019-2022 | |
| Stryker Corporation | $575.38 | 2019-2025 | Scopis Ent |
| Regeneron Healthcare Solutions, INC. | $383.52 | 2019-2025 | Dupixent, Libtayo |
| Medtronic, INC. | $209.58 | 2021-2025 | Stealthstation S8 Platform, Propel |
| Genzyme Corporation | $198.56 | 2022-2025 | |
| Glaxosmithkline, LLC. | $163.42 | 2021-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $120.58 | 2021-2025 | |
| Acclarent, INC | $105.83 | 2019-2021 | |
| Neurent Medical Limited | $89.87 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Kaleo, INC. | $60.82 | 2019-2022 | |
| Smith+Nephew, INC. | $41.95 | 2022 | |
| Organogenesis INC. | $25.47 | 2025 | Novachor |
| Greer Laboratories, INC. | $21.63 | 2022 | |
| Inspire Medical Systems, INC. | $20.53 | 2025 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $19.82 | 2023 | |
| Aerin Medical INC. | $17.48 | 2020 | |
| Merck Sharp & Dohme LLC | $16.67 | 2021 | |
| Philips North America LLC | $15.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lollar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.